Analysed SUNSHINE BIOPHARMA INC -27 (SBFMW:NASDAQ) News Sources
Health Canada Approves Sunshine Biopharma's Ondansetron for Treatment of Chemotherapy-Induced Nausea and Vomiting
28-07-2026
yahoo.com
EXCLUSIVE: Sunshine Biopharma Targets Canadian Market with New Women's Health Drug Approval
04-08-2026
yahoo.com
Sunshine Biopharma Enters the $2.8 Billion Global Dienogest Market with Canadian Regulatory Approval
04-08-2026
yahoo.com
Sunshine Biopharma Launches Amoxicillin in Canada and Begins Pharmacy Shipments, Targeting an Estimated $4.9 Billion Global Market
07-08-2026
yahoo.com
EXCLUSIVE: Sunshine Biopharma Secures Canadian Approval for Generic Hypertension Drug
19-08-2026
yahoo.com
Sunshine Biopharma Receives Canadian Regulatory Approval for Enalapril, Expanding Into $25.94 Billion Global Anti-Hypertensive Drug Market
19-08-2026
yahoo.com
A Multibillion-Dollar mRNA Cancer Market Is Taking Shape Targeting Lung Cancer’s Biggest Opportunity
26-08-2026
yahoo.com
Health Canada Approves Sunshine Biopharma's Atenolol for Treating and Managing Cardiovascular Conditions
31-08-2026
yahoo.com
What is the current price of SUNSHINE BIOPHARMA INC -27 (SBFMW:NASDAQ)?
The current price of SUNSHINE BIOPHARMA INC -27 (SBFMW:NASDAQ) is $0.031.
SUNSHINE BIOPHARMA INC -27 (SBFMW:NASDAQ) absolute price change since previous trading day?
The absolute price change of SUNSHINE BIOPHARMA INC -27 (SBFMW:NASDAQ) since the previous trading day is $-0.00945.
SUNSHINE BIOPHARMA INC -27 (SBFMW:NASDAQ) percentage price change since previous trading day?
The percentage price change of SUNSHINE BIOPHARMA INC -27 (SBFMW:NASDAQ) since the previous trading day is -23.3622%.
What is the most recent average sentiment score for SUNSHINE BIOPHARMA INC -27 (SBFMW:NASDAQ)?
The most recent average sentiment score for SUNSHINE BIOPHARMA INC -27 (SBFMW:NASDAQ) is 80 out of 100.
What is the most recent average sentiment for SUNSHINE BIOPHARMA INC -27 (SBFMW:NASDAQ)?
The most recent sentiment for SUNSHINE BIOPHARMA INC -27 (SBFMW:NASDAQ) is .
SEC-8K** Filing Available For SUNSHINE BIOPHARMA INC -27 (SBFMW:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.